Delivery Order SPE2DR25D3501-SPE2DR26FL9GU
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Lo Loestrin Fe 1/10 tablets in 28-count packaging. This is a firm fixed-price delivery order with a ceiling value of $1,226.80, with an ultimate completion date of November 18, 2025. The contract was competitively awarded with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $3,623.33 to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Lo Loestrin Fe 1-10 tablets (28-count packages). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and a completion date of December 9, 2025. The order will be fulfilled at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania, where the company operates as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $7,793.99 firm fixed-price delivery order for Lo Loestrin Fe 1-10 tablets (28-count supply) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in a 28-tablet package configuration. This firm fixed price delivery order, valued at $1,966.22, represents a non-competitive set-aside award and is scheduled for completion by November 28, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $37,032.75 to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablet 28-count units. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 3, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply...
- The Defense Logistics Agency awarded a $1,860.13 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin Fe 1-10 tablets (28-count packaging) under a firm fixed price contract type. The award, issued on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive, non-set-aside delivery order. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, where the performance location is also based, is a major pharmaceutical distributor serving...
- The Defense Logistics Agency awarded a delivery order valued at $10,943.58 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lo Loestrin Fe 1-10 Tablet 28-count packages. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a continuation of pharmaceutical procurement under the company's broader contractual relationship with the federal government. The product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $9,909.91 delivery order to AmerisourceBergen Drug Corp for Lo Loestrin FE 1-10 Tablets (28-count packages) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and was not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 11, 2025, for the supply of Lo Loestrin Fe 1-10 tablets in quantities of 28 units, with a ceiling value of $4,280.10. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively. The contract is expected to be completed by December 12, 2025, and the product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $6,942.24 to AmerisourceBergen Drug Corp for the supply of Lo Loestrin FE 1-10 tablets (28-count packages). This is a firm fixed-price, non-set-aside contract with a completion date of September 19, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and holds a significant indefinite delivery contract with DLA Troop Support Medical...
- SPE2DR25D3501Indefinite Delivery Contract
- SPE2DR25D3501-SPE2DR26FL9GUDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lo Loestrin Fe 1-10 tablets (28-count packages) under a firm fixed-price contract valued at $5,645.59. This is a non-set-aside competitive award with an ultimate completion date of November 25, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Lo Loestrin Fe delivery exemplifies the company's role as a critical vendor for federal medical procurement, providing both brand-name and generic medications across multiple therapeutic domains to support military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 11/23/25 |